Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

1,630 public trials 214 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Completed

Study of Untreated or Transformed Follicular Non-Hodgkin's Lymphoma With Fission-Derived Iodine I 131 Tositumomab

NCT00062894

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Bay Pines VA Medical Center Bay Pines, Florida, United States
  • Rush Medical Center Chicago, Illinois, United States
  • University of Michigan Medical Center Ann Arbor, Michigan, United States
  • University of Nebraska Medical Center Omaha, Nebraska, United States
View Trial Details
Completed

Study Evaluating the Safety and Effectiveness of ABT-510 in Subjects With Refractory Lymphoma

NCT00061672

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin's Lymphoma, +8 more
Locations
  • Hematology Oncology Associates Phoenix, Arizona, United States
  • Arizona Clinical Research Center Tucson, Arizona, United States
  • USC - Norris Cancer Center Los Angeles, California, United States
  • The Center for Hematology-Oncology Boca Raton, Florida, United States
View all 14 locations
View Trial Details
Completed

Cisplatin With Gemcitabine With Dexamethasone in Patients With Aggressive Non-Hodgkin's Lymphoma

NCT00491127

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain
View Trial Details
Completed

Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia

NCT00039910

Conditions
Blood Platelet Disorders, Cytopenia, Hematologic Diseases, +12 more
Locations
  • Pfizer Investigational Site Phoenix, Arizona, United States
  • Pfizer Investigational Site La Jolla, California, United States
  • Pfizer Investigational Site Loma Linda, California, United States
  • Pfizer Investigational Site Los Angeles, California, United States
View all 38 locations
View Trial Details
Completed

Infusion of Specially Treated Umbilical Cord Stem Cells After Chemoradiation Treatment for Blood Cancers

NCT00089596

Conditions
Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +25 more
Locations
  • Loyola University Medical Center Maywood, Illinois, United States
  • Indiana University Cancer Center Indianapolis, Indiana, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
View Trial Details

Related conditions